Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FONDAPARINUX Cause Heparin-induced thrombocytopenia? 76 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Heparin-induced thrombocytopenia have been filed in association with FONDAPARINUX (Fondaparinux Sodium). This represents 3.4% of all adverse event reports for FONDAPARINUX.

76
Reports of Heparin-induced thrombocytopenia with FONDAPARINUX
3.4%
of all FONDAPARINUX reports
8
Deaths
36
Hospitalizations

How Dangerous Is Heparin-induced thrombocytopenia From FONDAPARINUX?

Of the 76 reports, 8 (10.5%) resulted in death, 36 (47.4%) required hospitalization, and 14 (18.4%) were considered life-threatening.

Is Heparin-induced thrombocytopenia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FONDAPARINUX. However, 76 reports have been filed with the FAERS database.

What Other Side Effects Does FONDAPARINUX Cause?

Off label use (356) Haematoma (168) Anaemia (159) Drug ineffective (117) Pulmonary embolism (97) Haemorrhage (89) Cerebral haemorrhage (78) Thrombocytopenia (72) Thrombosis (71) Shock haemorrhagic (67)

What Other Drugs Cause Heparin-induced thrombocytopenia?

HEPARIN (2,057) ENOXAPARIN (435) ARGATROBAN (91) DALTEPARIN (66) BIVALIRUDIN (61) WARFARIN (50) ASPIRIN (44) CLOPIDOGREL BISULFATE (43) APIXABAN (32) RIVAROXABAN (32)

Which FONDAPARINUX Alternatives Have Lower Heparin-induced thrombocytopenia Risk?

FONDAPARINUX vs FORMOTEROL FONDAPARINUX vs FORMOTEROL\GLYCOPYRROLATE FONDAPARINUX vs FORMOTEROL\MOMETASONE FONDAPARINUX vs FORMOTEROL\MOMETASONE FUROATE FONDAPARINUX vs FORTEO

Related Pages

FONDAPARINUX Full Profile All Heparin-induced thrombocytopenia Reports All Drugs Causing Heparin-induced thrombocytopenia FONDAPARINUX Demographics